GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Price-to-Owner-Earnings

IQMDU (Intelligent Medicine Acquisition) Price-to-Owner-Earnings : (As of May. 17, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Intelligent Medicine Acquisition Price-to-Owner-Earnings?

As of today (2025-05-17), Intelligent Medicine Acquisition's share price is $10.98. Intelligent Medicine Acquisition does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Intelligent Medicine Acquisition's Price-to-Owner-Earnings or its related term are showing as below:


IQMDU's Price-to-Owner-Earnings is not ranked *
in the Diversified Financial Services industry.
Industry Median: 12.58
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-17), Intelligent Medicine Acquisition's share price is $10.98. Intelligent Medicine Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00. Therefore, Intelligent Medicine Acquisition's PE Ratio (TTM) for today is N/A.

As of today (2025-05-17), Intelligent Medicine Acquisition's share price is $10.98. Intelligent Medicine Acquisition's EPS without NRI for the trailing twelve months (TTM) ended in was $0.00. Therefore, Intelligent Medicine Acquisition's PE Ratio without NRI for today is N/A.

During the past 2 years, Intelligent Medicine Acquisition's highest PE Ratio without NRI was 94.45. The lowest was 0.00. And the median was 0.00.

Intelligent Medicine Acquisition Price-to-Owner-Earnings Historical Data

The historical data trend for Intelligent Medicine Acquisition's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Medicine Acquisition Price-to-Owner-Earnings Chart

Intelligent Medicine Acquisition Annual Data
Trend Dec21 Dec22
Price-to-Owner-Earnings
- -

Intelligent Medicine Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Intelligent Medicine Acquisition's Price-to-Owner-Earnings

For the Shell Companies subindustry, Intelligent Medicine Acquisition's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intelligent Medicine Acquisition's Price-to-Owner-Earnings Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Intelligent Medicine Acquisition's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Intelligent Medicine Acquisition's Price-to-Owner-Earnings falls into.


;
;

Intelligent Medicine Acquisition Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Intelligent Medicine Acquisition's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=10.98/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intelligent Medicine Acquisition  (NAS:IQMDU) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

Intelligent Medicine Acquisition Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Intelligent Medicine Acquisition's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelligent Medicine Acquisition Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Price-to-Owner-Earnings
Comparable Companies
IFIN WAVC FRW SHCA AVAC OCA ISLE BIOT DWIN TRCA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
9001 Burdette Road, Bethesda, MD, USA, 20817
Website
https://iqmdspac.com
Intelligent Medicine Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Joseph L Schocken director 2800 UNION SQUARE, 600 UNIVERSITY STREET, SEATTLE WA 98101
Kavita Patel director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jack Hidary director 3 PARK AVENUE, NEW YORK NY 10016
Gregory C Simon director, officer: CEO and CFO 9001 BURDETTE RD., BETHESDA MD 20817
Patience Marime-ball director 9001 BURDETTE RD., BETHESDA MD 20817
Intelligent Medicine Sponsor Llc 10 percent owner 9001 BURDETTE ROAD, BETHESDA MD 20817